Amiodarone-induced neuromyopathy in a geriatric patient

BMJ Case Rep. 2020 Nov 4;13(11):e236620. doi: 10.1136/bcr-2020-236620.

Abstract

Amiodarone is an antiarrhythmic medication with many side effects. Neuromyopathy is a rare adverse effect. We present an 87-year-old woman with bilateral leg pain and weakness in the context of amiodarone. She was admitted to the Acute Geriatric Unit in Calgary, Alberta, Canada. On examination, hip flexor and extensor strength were 2/5 bilaterally while knee flexor and extensor strength were 4/5 and 3/5, respectively. Creatine kinase and C-reactive protein levels were normal. MRI of the lumbar spine showed mild central canal stenosis. Electromyography and nerve conduction testing showed a severe axonal length-dependent polyneuropathy of the left lower extremity. There was evidence of myopathic changes to the left iliopsoas muscle. Overall, a neuromyopathic process affecting the lower extremities was supported. After discontinuation of amiodarone, mobility and function significantly improved. Although a rare complication of amiodarone, neuromyopathy should be considered in patients with compatible symptomatology.

Keywords: arrhythmias; geriatric medicine; muscle disease; unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Amiodarone / adverse effects*
  • Anti-Arrhythmia Agents / adverse effects
  • Atrial Fibrillation / drug therapy
  • Electromyography
  • Female
  • Humans
  • Lower Extremity
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiopathology*
  • Neuromuscular Diseases / chemically induced*
  • Neuromuscular Diseases / diagnosis
  • Neuromuscular Diseases / physiopathology
  • Tomography, X-Ray Computed

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone